Fusion Antibodies and BioTickle partnership delivers value with proprietary antibody discovery, engineering and cell line technologies Belfast, UK – (22 July 2021) – Fusion Antibodies, pre-clinical antibody discovery and development experts and BioTickle, their exclusive distributor in India, are providing local biopharmaceutical organisations with access to invaluable unique biopharmaceutical development capabilities. As Dr Richard Jones, […]
With their high specificity, efficacy and safety profiles, it’s no wonder that antibodies have become the biggest selling drugs in recent years. Advances in antibody discovery, selection and manufacturing have catapulted therapeutic antibodies to become the primary treatment for several diseases and the market shows no sign of abating, with the industry expected to be […]
Fusion Antibodies appoint Jenna Hewitt as R&D Director. This newly created position within the organisation represents the tremendous growth Fusion has undergone and marks the start of an exciting new era as the company looks to further expand its services to best support its customers.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.